INDIA PHARMA 2025
“Innovate in India, Innovate for the World”
3rd–4th November 2025 
The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, along with the Federation of Indian Chambers of Commerce & Industry (FICCI) has been actively working towards growth of pharmaceutical sector. Since the objective has always been to encourage and bring forward best technology solutions and manufacturing, therefore, Department of Pharmaceuticals announced India Pharma series of events which is an annual activity

Key Highlights of the 9th Edition of India Pharma 2025

Global Partnerships for expanding India’s pharmaceutical leadership

Attracting the Next Wave of GCCs

Unleashing India’s CRDMO Potential

AI/ML enabled Drug Discovery

States’ Investment Session: with focus on creating API resilience by Invest India

Accelerating Innovation: Regulatory Pathways

IMPACT OF THE PHARMA INDUSTRY ON THE INDIAN ECONOMY IN THE POST-COVID ERA
A report by KPMG in India and FICCI
Click here to Download
ONE PAGE DIGITAL ADVERTISEMENTS OF THE FOLLOWING INDIA PHARMA 2022 SPONSORS
Click here to Download

Post Show Report

Sponsorship

INDUSTRY OVERVIEW
  • India being the largest provider of generic medicines globally, occupying a 20% share in global supply by volume, supplying 62% of Global Vaccine demand is a prominent and rapidly growing presence in the global pharmaceuticals industry.
  • India ranks 3rd worldwide for production by volume and 14th by value
  • India is home to more than 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities offering over 60,000 generic brands across 60 therapeutic categories.
  • India has the highest number of US-FDA compliant Pharma plants outside of USA and its API industry is third largest in the world, with 57% of APIs on the WHO.
PHOTO GALLERY

Social Network

Facebook

Instagram

Countdown